At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01951 JXR
Market Closed 04-17 16:08:14
2.360
-0.050
-2.07%
High2.410Low2.350Vol16.29M
Open2.410D1 Closing2.410Amplitude2.49%
Mkt Cap6.38BTradable Cap6.38BTotal Shares2.71B
T/O38.59MT/O Rate0.60%Tradable Shares2.71B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
JXR Allocates HK$4.96 Million to Repurchase 2.066 Million Shares on April 15
Stock News  ·  04-15
JXR Allocates HK$4.96 Million to Repurchase 2.066 Million Shares on April 15
JXR repurchases 3.20 million shares; outstanding buybacks awaiting cancellation reach 9.51 million
Bulletin Express  ·  04-10
JXR repurchases 3.20 million shares; outstanding buybacks awaiting cancellation reach 9.51 million
JXR Allocates HK$7.89 Million for Share Buyback on April 10
Stock News  ·  04-10
JXR Allocates HK$7.89 Million for Share Buyback on April 10
Jinxin Fertility files HKEX next-day return disclosing HKD 2.47 share buyback price
Reuters  ·  04-10
Jinxin Fertility files HKEX next-day return disclosing HKD 2.47 share buyback price
JXR trims outstanding shares by 52.66 million via HKD 2.53 buyback and treasury cancellation
Bulletin Express  ·  04-09
JXR trims outstanding shares by 52.66 million via HKD 2.53 buyback and treasury cancellation
JXR Cancels 39.66 Million Repurchased Shares on April 9
Stock News  ·  04-09
JXR Cancels 39.66 Million Repurchased Shares on April 9
Jinxin Fertility files HKEX next-day return disclosing buyback at HKD 2.53/share
Reuters  ·  04-09
Jinxin Fertility files HKEX next-day return disclosing buyback at HKD 2.53/share
JXR Maintains Capital Structure in March 2026; 45.97 Million Repurchased Shares Pending Cancellation
Bulletin Express  ·  04-09
JXR Maintains Capital Structure in March 2026; 45.97 Million Repurchased Shares Pending Cancellation
JXR executes HKD 4.62 million buyback; cumulative repurchases reach 45.97 million shares (1.67% of share capital)
Bulletin Express  ·  03-31
JXR executes HKD 4.62 million buyback; cumulative repurchases reach 45.97 million shares (1.67% of share capital)
Jinxin Fertility Retains Outperform Rating from CICC with HK$3.50 Price Target
Stock News  ·  03-31
Jinxin Fertility Retains Outperform Rating from CICC with HK$3.50 Price Target
JXR Allocates HK$1.93 Million for Share Buyback on March 30
Stock News  ·  03-31
JXR Allocates HK$1.93 Million for Share Buyback on March 30
JXR acquires 3.52 million shares in latest buyback; cumulative repurchases reach 1.57 % of mandate
Bulletin Express  ·  03-30
JXR acquires 3.52 million shares in latest buyback; cumulative repurchases reach 1.57 % of mandate
JXR updates share buyback activity: HK$8.05 million spent in latest repurchase; 43.18 million shares pending cancellation
Bulletin Express  ·  03-27
JXR updates share buyback activity: HK$8.05 million spent in latest repurchase; 43.18 million shares pending cancellation
Jinxin Fertility Group FY 2025 Loss Spurs Debate On Premium Valuation Narratives
Simply Wall St.  ·  03-27
Jinxin Fertility Group FY 2025 Loss Spurs Debate On Premium Valuation Narratives
Leading IVF Provider Faces Historic Loss Amid Industry Challenges
Deep News  ·  03-27
Leading IVF Provider Faces Historic Loss Amid Industry Challenges
JXR Reports Annual Revenue of 2.649 Billion Yuan with 28,039 Egg Retrieval Cycles
Deep News  ·  03-27
JXR Reports Annual Revenue of 2.649 Billion Yuan with 28,039 Egg Retrieval Cycles
JXR Reports Adjusted Net Profit of Approximately 209 Million Yuan for 2025, Declares Final Dividend of 4.18 HK Cents Per Share
Stock News  ·  03-26
JXR Reports Adjusted Net Profit of Approximately 209 Million Yuan for 2025, Declares Final Dividend of 4.18 HK Cents Per Share
BRIEF-Jinxin Fertility Posts FY Revenue RMB 2,649.1 Million
Reuters  ·  03-26
BRIEF-Jinxin Fertility Posts FY Revenue RMB 2,649.1 Million
Jinxin Fertility (JXR): 2025 Swings to RMB983.90 Million Loss on Goodwill Impairment; Revenue Slides 5.8%
Bulletin Express  ·  03-26
Jinxin Fertility (JXR): 2025 Swings to RMB983.90 Million Loss on Goodwill Impairment; Revenue Slides 5.8%
Jinxin Fertility announces RMB100 million FY2025 final dividend, introduces 50%–80% EBITDA shareholder return plan and RMB300 million buyback
Bulletin Express  ·  03-26
Jinxin Fertility announces RMB100 million FY2025 final dividend, introduces 50%–80% EBITDA shareholder return plan and RMB300 million buyback

Introduction

Company Name.
JXR
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Jinxin Fertility Group Ltd is an investment holding company principally engaged in the provision of in-vitro fertilization (IVF) services. Through its subsidiaries, the Company mainly provides assisted reproductive services, management services, ambulatory surgery center facilities services, ancillary medical services, obstetrics, gynecology and pediatrics medical services, as well as the sales of medical consumables and equipment. The Company mainly provides its services in both China and the United States.
Issue price:
--